Company: RGNT
Filing Date: 2025-01-27
Form Type: DRS/A
Source: 0001213900-25-006676
Chunk: 125

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-01-27
Form: DRS/A
Chunk 125
---
 US 9,624,259 and EP 2497505, which are detailed in the table below.

Family 

# 4 derived from WO 2014/207749
filed June 24, 2014 claims an injectable curable paste that can be shaped to fill defects requiring treatment. The family of patent applications
derived from WO 2014/207749 includes patents Nos. US 10,434,215, EP 3013377 and CN 105407933, which are detailed in the table below.

Family #6 derived from WO
2015/052708 filed January 24, 2014 claim an apparatus for treatment of cavities in a human body. The family of patent applications
derived from WO 2015/052708 includes patents Nos. US 9,895,519, US 9,872,705, EP 2874546, CN 106232023 and IL 235270, which are
detailed in the table below.

The patent portfolio of the
Company includes granted patents that cover the products currently in development and additional families of patents that may provide
supplementary protection for those products and further products.

<div align='center'>76</div>

Patents

As of January 2025, our exclusively
owned patent portfolio includes thirty-four (34) issued patents, of which eight (8) are U.S. patents and twenty-six (26) are foreign patents,
with eighteen (18) of the twenty-six (26) foreign patents being nationally validated in certain European extension/validation states).
In addition, one U.S. patent application and two patent applications are pending. The claims of the owned patents and patent applications
below are directed toward various aspects of our family of products, methods of their manufacturing, delivery device and research programs.

| Effective     
 Filing Date   |     | Patent No.   |     | Title                                                                                                                                  |     | Country                                       |     | Product     |     | Type of patent protection |     | Expiry date   |
| Dec. 15, 2004 |     | US 8,007,774 |     | Matrix composed of a naturally-occurring protein backbone cross linked by a synthetic polymer and methods of generating and using same |     | USA                                           |     | GelrinC     |     | Utility patent            |     | Dec. 31, 2025 |
| Dec. 15, 2004 |     | US 9,120,872